First Header Logo Second Header Logo

Search Results (232)

MatchTypeWhy
The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: provider practices and beliefs about allergen immunotherapy.Academic Article Why?
The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) survey: patients' experience with allergen immunotherapy.Academic Article Why?
Neurological Complications of Immunotherapies-Beware of the Checkpoint Ahead.Academic Article Why?
Re-inventing intratumoral immunotherapy for melanoma.Academic Article Why?
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.Academic Article Why?
Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.Academic Article Why?
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.Academic Article Why?
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.Academic Article Why?
Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.Academic Article Why?
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Academic Article Why?
Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena.Academic Article Why?
Immunotherapy as a potential treatment approach for currently incurable bone metastasis.Academic Article Why?
Impact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer.Academic Article Why?
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).Academic Article Why?
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.Academic Article Why?
Per Page    Page  of 16last Nextnext
Prev
Search Criteria
  • immunotherapy
Filter by Type
_
Click "Why?" to see why an item matched the search.